Global Mycoplasma Hyopneumoniae Vaccine Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Mycoplasma Hyopneumoniae Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Mycoplasma Hyopneumoniae Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Mycoplasma Hyopneumoniae Vaccine by Country/Region, 2017, 2022 & 2028

2.2 Mycoplasma Hyopneumoniae Vaccine Segment by Type

2.2.1 Live

2.2.2 Inactivated

2.3 Mycoplasma Hyopneumoniae Vaccine Sales by Type

2.3.1 Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global Mycoplasma Hyopneumoniae Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Mycoplasma Hyopneumoniae Vaccine Sale Price by Type (2017-2022)

2.4 Mycoplasma Hyopneumoniae Vaccine Segment by Application

2.4.1 Piglets

2.4.2 Adult Pigs

2.5 Mycoplasma Hyopneumoniae Vaccine Sales by Application

2.5.1 Global Mycoplasma Hyopneumoniae Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global Mycoplasma Hyopneumoniae Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Mycoplasma Hyopneumoniae Vaccine Sale Price by Application (2017-2022)

3 Global Mycoplasma Hyopneumoniae Vaccine by Company

3.1 Global Mycoplasma Hyopneumoniae Vaccine Breakdown Data by Company

3.1.1 Global Mycoplasma Hyopneumoniae Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Company (2020-2022)

3.2 Global Mycoplasma Hyopneumoniae Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global Mycoplasma Hyopneumoniae Vaccine Revenue by Company (2020-2022)

3.2.2 Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global Mycoplasma Hyopneumoniae Vaccine Sale Price by Company

3.4 Key Manufacturers Mycoplasma Hyopneumoniae Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Mycoplasma Hyopneumoniae Vaccine Product Location Distribution

3.4.2 Players Mycoplasma Hyopneumoniae Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Mycoplasma Hyopneumoniae Vaccine by Geographic Region

4.1 World Historic Mycoplasma Hyopneumoniae Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global Mycoplasma Hyopneumoniae Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Mycoplasma Hyopneumoniae Vaccine Annual Revenue by Geographic Region

4.2 World Historic Mycoplasma Hyopneumoniae Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global Mycoplasma Hyopneumoniae Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Mycoplasma Hyopneumoniae Vaccine Annual Revenue by Country/Region

4.3 Americas Mycoplasma Hyopneumoniae Vaccine Sales Growth

4.4 APAC Mycoplasma Hyopneumoniae Vaccine Sales Growth

4.5 Europe Mycoplasma Hyopneumoniae Vaccine Sales Growth

4.6 Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales Growth

5 Americas

5.1 Americas Mycoplasma Hyopneumoniae Vaccine Sales by Country

5.1.1 Americas Mycoplasma Hyopneumoniae Vaccine Sales by Country (2017-2022)

5.1.2 Americas Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2017-2022)

5.2 Americas Mycoplasma Hyopneumoniae Vaccine Sales by Type

5.3 Americas Mycoplasma Hyopneumoniae Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Mycoplasma Hyopneumoniae Vaccine Sales by Region

6.1.1 APAC Mycoplasma Hyopneumoniae Vaccine Sales by Region (2017-2022)

6.1.2 APAC Mycoplasma Hyopneumoniae Vaccine Revenue by Region (2017-2022)

6.2 APAC Mycoplasma Hyopneumoniae Vaccine Sales by Type

6.3 APAC Mycoplasma Hyopneumoniae Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Mycoplasma Hyopneumoniae Vaccine by Country

7.1.1 Europe Mycoplasma Hyopneumoniae Vaccine Sales by Country (2017-2022)

7.1.2 Europe Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2017-2022)

7.2 Europe Mycoplasma Hyopneumoniae Vaccine Sales by Type

7.3 Europe Mycoplasma Hyopneumoniae Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Mycoplasma Hyopneumoniae Vaccine by Country

8.1.1 Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales by Type

8.3 Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Mycoplasma Hyopneumoniae Vaccine

10.3 Manufacturing Process Analysis of Mycoplasma Hyopneumoniae Vaccine

10.4 Industry Chain Structure of Mycoplasma Hyopneumoniae Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Mycoplasma Hyopneumoniae Vaccine Distributors

11.3 Mycoplasma Hyopneumoniae Vaccine Customer

12 World Forecast Review for Mycoplasma Hyopneumoniae Vaccine by Geographic Region

12.1 Global Mycoplasma Hyopneumoniae Vaccine Market Size Forecast by Region

12.1.1 Global Mycoplasma Hyopneumoniae Vaccine Forecast by Region (2023-2028)

12.1.2 Global Mycoplasma Hyopneumoniae Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Mycoplasma Hyopneumoniae Vaccine Forecast by Type

12.7 Global Mycoplasma Hyopneumoniae Vaccine Forecast by Application

13 Key Players Analysis

13.1 Zoetis

13.1.1 Zoetis Company Information

13.1.2 Zoetis Mycoplasma Hyopneumoniae Vaccine Product Offered

13.1.3 Zoetis Mycoplasma Hyopneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Zoetis Main Business Overview

13.1.5 Zoetis Latest Developments

13.2 Merck

13.2.1 Merck Company Information

13.2.2 Merck Mycoplasma Hyopneumoniae Vaccine Product Offered

13.2.3 Merck Mycoplasma Hyopneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Merck Main Business Overview

13.2.5 Merck Latest Developments

13.3 Boehringer Ingelheim

13.3.1 Boehringer Ingelheim Company Information

13.3.2 Boehringer Ingelheim Mycoplasma Hyopneumoniae Vaccine Product Offered

13.3.3 Boehringer Ingelheim Mycoplasma Hyopneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Boehringer Ingelheim Main Business Overview

13.3.5 Boehringer Ingelheim Latest Developments

13.4 Ceva Santé Animale

13.4.1 Ceva Santé Animale Company Information

13.4.2 Ceva Santé Animale Mycoplasma Hyopneumoniae Vaccine Product Offered

13.4.3 Ceva Santé Animale Mycoplasma Hyopneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Ceva Santé Animale Main Business Overview

13.4.5 Ceva Santé Animale Latest Developments

13.5 Elanco Animal Health

13.5.1 Elanco Animal Health Company Information

13.5.2 Elanco Animal Health Mycoplasma Hyopneumoniae Vaccine Product Offered

13.5.3 Elanco Animal Health Mycoplasma Hyopneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Elanco Animal Health Main Business Overview

13.5.5 Elanco Animal Health Latest Developments

13.6 Qilu Animal Health

13.6.1 Qilu Animal Health Company Information

13.6.2 Qilu Animal Health Mycoplasma Hyopneumoniae Vaccine Product Offered

13.6.3 Qilu Animal Health Mycoplasma Hyopneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Qilu Animal Health Main Business Overview

13.6.5 Qilu Animal Health Latest Developments

13.7 Ruipu

13.7.1 Ruipu Company Information

13.7.2 Ruipu Mycoplasma Hyopneumoniae Vaccine Product Offered

13.7.3 Ruipu Mycoplasma Hyopneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Ruipu Main Business Overview

13.7.5 Ruipu Latest Developments

13.8 Shanghai Hile Bio-Technology Co., Ltd.

13.8.1 Shanghai Hile Bio-Technology Co., Ltd. Company Information

13.8.2 Shanghai Hile Bio-Technology Co., Ltd. Mycoplasma Hyopneumoniae Vaccine Product Offered

13.8.3 Shanghai Hile Bio-Technology Co., Ltd. Mycoplasma Hyopneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Shanghai Hile Bio-Technology Co., Ltd. Main Business Overview

13.8.5 Shanghai Hile Bio-Technology Co., Ltd. Latest Developments

13.9 CAHIC

13.9.1 CAHIC Company Information

13.9.2 CAHIC Mycoplasma Hyopneumoniae Vaccine Product Offered

13.9.3 CAHIC Mycoplasma Hyopneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 CAHIC Main Business Overview

13.9.5 CAHIC Latest Developments

13.10 Pulike

13.10.1 Pulike Company Information

13.10.2 Pulike Mycoplasma Hyopneumoniae Vaccine Product Offered

13.10.3 Pulike Mycoplasma Hyopneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Pulike Main Business Overview

13.10.5 Pulike Latest Developments

13.11 Harbin Pharmaceutical Group

13.11.1 Harbin Pharmaceutical Group Company Information

13.11.2 Harbin Pharmaceutical Group Mycoplasma Hyopneumoniae Vaccine Product Offered

13.11.3 Harbin Pharmaceutical Group Mycoplasma Hyopneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Harbin Pharmaceutical Group Main Business Overview

13.11.5 Harbin Pharmaceutical Group Latest Developments

14 Research Findings and Conclusion

Table 1. Mycoplasma Hyopneumoniae Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Mycoplasma Hyopneumoniae Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Live

Table 4. Major Players of Inactivated

Table 5. Global Mycoplasma Hyopneumoniae Vaccine Sales by Type (2017-2022) & (K Units)

Table 6. Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Type (2017-2022)

Table 7. Global Mycoplasma Hyopneumoniae Vaccine Revenue by Type (2017-2022) & ($ million)

Table 8. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Type (2017-2022)

Table 9. Global Mycoplasma Hyopneumoniae Vaccine Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Mycoplasma Hyopneumoniae Vaccine Sales by Application (2017-2022) & (K Units)

Table 11. Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Application (2017-2022)

Table 12. Global Mycoplasma Hyopneumoniae Vaccine Revenue by Application (2017-2022)

Table 13. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Application (2017-2022)

Table 14. Global Mycoplasma Hyopneumoniae Vaccine Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Mycoplasma Hyopneumoniae Vaccine Sales by Company (2020-2022) & (K Units)

Table 16. Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Company (2020-2022)

Table 17. Global Mycoplasma Hyopneumoniae Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Company (2020-2022)

Table 19. Global Mycoplasma Hyopneumoniae Vaccine Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Mycoplasma Hyopneumoniae Vaccine Producing Area Distribution and Sales Area

Table 21. Players Mycoplasma Hyopneumoniae Vaccine Products Offered

Table 22. Mycoplasma Hyopneumoniae Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Mycoplasma Hyopneumoniae Vaccine Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share Geographic Region (2017-2022)

Table 27. Global Mycoplasma Hyopneumoniae Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Mycoplasma Hyopneumoniae Vaccine Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Country/Region (2017-2022)

Table 31. Global Mycoplasma Hyopneumoniae Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Mycoplasma Hyopneumoniae Vaccine Sales by Country (2017-2022) & (K Units)

Table 34. Americas Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Country (2017-2022)

Table 35. Americas Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Country (2017-2022)

Table 37. Americas Mycoplasma Hyopneumoniae Vaccine Sales by Type (2017-2022) & (K Units)

Table 38. Americas Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Type (2017-2022)

Table 39. Americas Mycoplasma Hyopneumoniae Vaccine Sales by Application (2017-2022) & (K Units)

Table 40. Americas Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Application (2017-2022)

Table 41. APAC Mycoplasma Hyopneumoniae Vaccine Sales by Region (2017-2022) & (K Units)

Table 42. APAC Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Region (2017-2022)

Table 43. APAC Mycoplasma Hyopneumoniae Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Region (2017-2022)

Table 45. APAC Mycoplasma Hyopneumoniae Vaccine Sales by Type (2017-2022) & (K Units)

Table 46. APAC Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Type (2017-2022)

Table 47. APAC Mycoplasma Hyopneumoniae Vaccine Sales by Application (2017-2022) & (K Units)

Table 48. APAC Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Application (2017-2022)

Table 49. Europe Mycoplasma Hyopneumoniae Vaccine Sales by Country (2017-2022) & (K Units)

Table 50. Europe Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Country (2017-2022)

Table 51. Europe Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Country (2017-2022)

Table 53. Europe Mycoplasma Hyopneumoniae Vaccine Sales by Type (2017-2022) & (K Units)

Table 54. Europe Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Type (2017-2022)

Table 55. Europe Mycoplasma Hyopneumoniae Vaccine Sales by Application (2017-2022) & (K Units)

Table 56. Europe Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Mycoplasma Hyopneumoniae Vaccine

Table 66. Key Market Challenges & Risks of Mycoplasma Hyopneumoniae Vaccine

Table 67. Key Industry Trends of Mycoplasma Hyopneumoniae Vaccine

Table 68. Mycoplasma Hyopneumoniae Vaccine Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Mycoplasma Hyopneumoniae Vaccine Distributors List

Table 71. Mycoplasma Hyopneumoniae Vaccine Customer List

Table 72. Global Mycoplasma Hyopneumoniae Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Mycoplasma Hyopneumoniae Vaccine Sales Market Forecast by Region

Table 74. Global Mycoplasma Hyopneumoniae Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Mycoplasma Hyopneumoniae Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Mycoplasma Hyopneumoniae Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Mycoplasma Hyopneumoniae Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Mycoplasma Hyopneumoniae Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Mycoplasma Hyopneumoniae Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Mycoplasma Hyopneumoniae Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Mycoplasma Hyopneumoniae Vaccine Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Mycoplasma Hyopneumoniae Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Mycoplasma Hyopneumoniae Vaccine Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Mycoplasma Hyopneumoniae Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 92. Zoetis Basic Information, Mycoplasma Hyopneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 93. Zoetis Mycoplasma Hyopneumoniae Vaccine Product Offered

Table 94. Zoetis Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Zoetis Main Business

Table 96. Zoetis Latest Developments

Table 97. Merck Basic Information, Mycoplasma Hyopneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 98. Merck Mycoplasma Hyopneumoniae Vaccine Product Offered

Table 99. Merck Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. Merck Main Business

Table 101. Merck Latest Developments

Table 102. Boehringer Ingelheim Basic Information, Mycoplasma Hyopneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 103. Boehringer Ingelheim Mycoplasma Hyopneumoniae Vaccine Product Offered

Table 104. Boehringer Ingelheim Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. Boehringer Ingelheim Main Business

Table 106. Boehringer Ingelheim Latest Developments

Table 107. Ceva Santé Animale Basic Information, Mycoplasma Hyopneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 108. Ceva Santé Animale Mycoplasma Hyopneumoniae Vaccine Product Offered

Table 109. Ceva Santé Animale Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Ceva Santé Animale Main Business

Table 111. Ceva Santé Animale Latest Developments

Table 112. Elanco Animal Health Basic Information, Mycoplasma Hyopneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 113. Elanco Animal Health Mycoplasma Hyopneumoniae Vaccine Product Offered

Table 114. Elanco Animal Health Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. Elanco Animal Health Main Business

Table 116. Elanco Animal Health Latest Developments

Table 117. Qilu Animal Health Basic Information, Mycoplasma Hyopneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 118. Qilu Animal Health Mycoplasma Hyopneumoniae Vaccine Product Offered

Table 119. Qilu Animal Health Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. Qilu Animal Health Main Business

Table 121. Qilu Animal Health Latest Developments

Table 122. Ruipu Basic Information, Mycoplasma Hyopneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 123. Ruipu Mycoplasma Hyopneumoniae Vaccine Product Offered

Table 124. Ruipu Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. Ruipu Main Business

Table 126. Ruipu Latest Developments

Table 127. Shanghai Hile Bio-Technology Co., Ltd. Basic Information, Mycoplasma Hyopneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 128. Shanghai Hile Bio-Technology Co., Ltd. Mycoplasma Hyopneumoniae Vaccine Product Offered

Table 129. Shanghai Hile Bio-Technology Co., Ltd. Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. Shanghai Hile Bio-Technology Co., Ltd. Main Business

Table 131. Shanghai Hile Bio-Technology Co., Ltd. Latest Developments

Table 132. CAHIC Basic Information, Mycoplasma Hyopneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 133. CAHIC Mycoplasma Hyopneumoniae Vaccine Product Offered

Table 134. CAHIC Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 135. CAHIC Main Business

Table 136. CAHIC Latest Developments

Table 137. Pulike Basic Information, Mycoplasma Hyopneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 138. Pulike Mycoplasma Hyopneumoniae Vaccine Product Offered

Table 139. Pulike Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 140. Pulike Main Business

Table 141. Pulike Latest Developments

Table 142. Harbin Pharmaceutical Group Basic Information, Mycoplasma Hyopneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 143. Harbin Pharmaceutical Group Mycoplasma Hyopneumoniae Vaccine Product Offered

Table 144. Harbin Pharmaceutical Group Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 145. Harbin Pharmaceutical Group Main Business

Table 146. Harbin Pharmaceutical Group Latest Developments

List of Figures

Figure 1. Picture of Mycoplasma Hyopneumoniae Vaccine

Figure 2. Mycoplasma Hyopneumoniae Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Mycoplasma Hyopneumoniae Vaccine Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Mycoplasma Hyopneumoniae Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Mycoplasma Hyopneumoniae Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Live

Figure 10. Product Picture of Inactivated

Figure 11. Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Type in 2021

Figure 12. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Type (2017-2022)

Figure 13. Mycoplasma Hyopneumoniae Vaccine Consumed in Piglets

Figure 14. Global Mycoplasma Hyopneumoniae Vaccine Market: Piglets (2017-2022) & (K Units)

Figure 15. Mycoplasma Hyopneumoniae Vaccine Consumed in Adult Pigs

Figure 16. Global Mycoplasma Hyopneumoniae Vaccine Market: Adult Pigs (2017-2022) & (K Units)

Figure 17. Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Application (2017-2022)

Figure 18. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Application in 2021

Figure 19. Mycoplasma Hyopneumoniae Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Company in 2021

Figure 21. Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Geographic Region in 2021

Figure 23. Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Region (2017-2022)

Figure 24. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Country/Region in 2021

Figure 25. Americas Mycoplasma Hyopneumoniae Vaccine Sales 2017-2022 (K Units)

Figure 26. Americas Mycoplasma Hyopneumoniae Vaccine Revenue 2017-2022 ($ Millions)

Figure 27. APAC Mycoplasma Hyopneumoniae Vaccine Sales 2017-2022 (K Units)

Figure 28. APAC Mycoplasma Hyopneumoniae Vaccine Revenue 2017-2022 ($ Millions)

Figure 29. Europe Mycoplasma Hyopneumoniae Vaccine Sales 2017-2022 (K Units)

Figure 30. Europe Mycoplasma Hyopneumoniae Vaccine Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales 2017-2022 (K Units)

Figure 32. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Revenue 2017-2022 ($ Millions)

Figure 33. Americas Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Country in 2021

Figure 34. Americas Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Country in 2021

Figure 35. United States Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Region in 2021

Figure 40. APAC Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Regions in 2021

Figure 41. China Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Country in 2021

Figure 48. Europe Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Country in 2021

Figure 49. Germany Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Country in 2021

Figure 56. Egypt Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Mycoplasma Hyopneumoniae Vaccine in 2021

Figure 62. Manufacturing Process Analysis of Mycoplasma Hyopneumoniae Vaccine

Figure 63. Industry Chain Structure of Mycoplasma Hyopneumoniae Vaccine

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles